Iashia Nabi

Has grant

The University of Manchester
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

The role of the endothelial glycocalyx in leukocyte recruitment in lung inflammation / infection

Open Date: 2022-01-05

Close Date: 2025-09-30

Articles (5)

Year:

2026

The glycocalyx is a proteoglycan-rich layer present on the surface of all mammalian cells and is particularly prevalent on endothelial cells lining the vasculature. The glycocalyx is thought to affect leukocyte migration by masking adhesion molecules and reducing leukocyte adhesion to the endothelium. Leukocyte recruitment is a key driver of inflammatory diseases, including psoriasis. Here, we found that leukocytes had the glycocalyx component heparan sulfate on their cell surface and that it was lost in response to psoriasis-like skin inflammation. In contrast, endothelial heparan sulfate was not affected. Treatment with a heparan sulfate mimetic during psoriasis-like skin inflammation in mice protected heparan sulfate from cleavage by myeloid cell–derived heparanase and resulted in reduced leukocyte accumulation in the skin. However, clinical signs of inflammation were increased because of the reduced numbers of T regulatory cells that were recruited. These findings refine our understanding of immune cell recruitment by revealing the presence and function of a heparan sulfate glycocalyx on immune cells and highlight the complex effects of heparanase inhibitors on the immune response in this context.

Year:

2025

The glycocalyx is a proteoglycan-rich layer present on the surface of all mammalian cells that is particularly prevalent on endothelial cells lining the vasculature. It has been hypothesized that the glycocalyx mediates leukocyte migration by masking adhesion molecules and reducing leukocyte adhesion to the endothelium. Leukocyte recruitment is a key driver of inflammatory diseases, including the chronic skin disease, psoriasis. Here, we show that leukocytes express heparan sulfate, an important glycocalyx component, on their cell surface which is lost in response to psoriasis-like skin inflammation, whilst endothelial heparan sulfate expression is not affected. Treatment with a heparan sulfate mimetic during psoriasis-like skin inflammation protected heparan sulfate from cleavage by heparanase and resulted in reduced leukocyte accumulation in skin, yet unexpectedly, led to increased clinical signs of inflammation due to reduced Treg numbers. These findings reshape our understanding of immune cell recruitment by revealing the presence and function of a heparan sulfate glycocalyx on immune cells and highlight the complex effects of heparanase inhibitors on the immune response in this context. One Sentence Summary Leukocytes express a glycocalyx on their surface which is shed in response to psoriasis-like skin inflammation, facilitating their migration into the skin.

Year:

2024

Year:

2023

Year:

2023

Collaborators (9)

Rebecca Miller

Associate Professor

University of Copenhagen

DENMARK
View details

Olga V. Zubkova

Programme Leader, Senior Scientist

Victoria University of Wellington

NEW ZEALAND
View details

Amanda Ridley

The University of Manchester

UNITED KINGDOM
View details

Amy Saunders

Lecturer

University of Lancaster

UNITED KINGDOM
View details

Douglas Dyer

The University of Manchester

UNITED KINGDOM
View details

Ingo Schiessl

The University of Manchester

UNITED KINGDOM
View details

Tracy Hussell

The University of Manchester

UNITED KINGDOM
View details

Nabina Pun

University of Oxford

UNITED KINGDOM
View details

Max Nobis

Head

UCL Cancer Institute

BELGIUM
View details